title: L-carnitine and coenzyme Q10 protective action against ischaemia and reperfusion of working rat heart.
abstract: The protective effect of L-carnitine, coenzyme Q10 and their combination on haemodynamic and metabolic variables has been investigated in isolated perfused working rat hearts after 10 min of global normothermic ischaemia followed by 60 min of reperfusion. In untreated rats or in rats treated only with L-carnitine or with coenzyme Q10, this experimental condition did not induce any irreversible myocardial injury as measured by leakage of cardiac enzymes; however, it decreased some haemodynamic parameters such as cardiac output and minute work, as well as the ATP concentration and the total adenine nucleotide pool. No variations in haemodynamic and metabolic parameters were observed in the rats treated with L-carnitine plus coenzyme Q10. In the perfusate of the hearts of the rats treated with both compounds, a lower purine release (a good index of myocardial energy balance) was also obtained. Although the molecular mechanisms remain to be defined, it appears that the association of L-carnitine and coenzyme Q10 is more effective than using these compounds separately. The complementary and synergic actions of L-carnitine and coenzyme Q10 on metabolism and against peroxidation by oxygen reaction species may explain the efficacy of their association.
authors.affiliation: Institute of Biological Chemistry, University of Pisa, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bertelli
authors.forename: F
authors.initials: F
authors.lastname: Ronca
authors.forename: G
authors.initials: G
authors.lastname: Ronca
authors.forename: L
authors.initials: L
authors.lastname: Palmieri
authors.forename: R
authors.initials: R
authors.lastname: Zucchi
mesh_terms: D000818:Animals; D002331:Carnitine / Q000097:blood / Q000627:therapeutic use*; D002851:Chromatography, High Pressure Liquid; D003067:Coenzymes; D004338:Drug Combinations; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D017202:Myocardial Ischemia / Q000503:physiopathology / Q000517:prevention & control*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology / Q000517:prevention & control*; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D009711:Nucleotides / Q000097:blood; D010725:Phosphocreatine / Q000097:blood; D011687:Purines / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D003067:Coenzymes; D004338:Drug Combinations; D009711:Nucleotides; D011687:Purines; D010725:Phosphocreatine; D014451:Ubiquinone; C024989:coenzyme Q10; D002331:Carnitine